Gastric Varices Bleeding
11
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (11)
Efficacy and Safety of Contrast EUS-Guided Tissue Glue/Coil Devascularization vs. BRTO for Preventing Recurrent Gastric Variceal Bleeding
Detachable Clip-assisted Endoscopic Cyanoacrylate Injection in the Treatment of Gastric Varices
EUS Guided Coil Embolization for Primary Prophylaxis of Gastric Varices
Impact of EUS Guided Treatment of Gastric Varices
Primary Prevention of Gastric Varices Bleed
Preemptive TIPS for Gastric Variceal Bleeding in Patients With Cirrhosis
Balloon-occluded Retrograde Transvenous Obliteration for Gastric Variceal Rebleeding
MRI to Assess the Effect of Non-selective Beta-blocker in Patients With Cirrhosis
Safety of Anticoagulant Therapy After Tissue Glue for Gastric Varices
Interventional Devascularization Plus HVPG-Guided Carvedilol Therapy vs TIPS
Combined and Simultaneous Approach for the Treatment of High-risk Gastric Varices Using B-RTO and EVO